A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

Colaboración

Año: 2019

Elez, E; Pericay, C; Valladares-Ayerbes, M; Bando, I; Safont, MJ; Gallego, J; Gravalos, C; Arrivi, A; Carrato, A; Conde, V; Ortiz, MJ; Lopez, C; Alonso, B; de Mena, IR; Diaz-Rubio, E; Tabernero, J; Aranda, E

Título: BRITISH JOURNAL OF CANCER

• Q1